Cyhoeddiadau
2024
- CyhoeddwydA hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trial
Smith, T., West, C., Joseph, N., Lane, B., Irlam-Jones, J., More, E., Mistry, H., Reeves, K., Song, Y. P., Reardon, M., Hoskin, P., Hussain, S., Denley, H., Hall, E., Porta, N., Huddart, R., James, N. & Choudhury, A., 1 Maw 2024, Yn: eBioMedicine. 101, t. 105032 14 t., 105032.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid - CyhoeddwydCRISPR–Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer
Smith, D., Lunj, S., Adamson, A., Nagarajan, S., Smith, T., Reeves, K., Hoskin, P. & Choudhury, A., 1 Gorff 2024, Yn: Nature Reviews Urology. 21, t. 1-11 11 t.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl adolygu › adolygiad gan gymheiriaid - CyhoeddwydGene Abnormalities and Modulated Gene Expression Associated with Radionuclide Treatment: Towards Predictive Biomarkers of Response
Smith, T., 26 Mai 2024, Yn: Genes. 15, 6, t. 688 16 t., 15060688.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl adolygu › adolygiad gan gymheiriaid - CyhoeddwydImplementation of Oxygen Enhanced Magnetic Resonance Imaging (OE-MRI) and a Pilot Genomic Study of Hypoxia in Bladder Cancer Xenografts
Shabbir, R., Telfer, B., Dickie, B., Reardon, M., Babur, M., Williams, K., Choudhury, A., West, C. & Smith, T., 27 Meh 2024, Yn: Cancer Genomics & Proteomics. 21, 4, t. 380-387 8 t.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid